# Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

> **NCT01310972** · — · COMPLETED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 6 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **OTHER:** Registry

## Key facts

- **NCT ID:** NCT01310972
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01310972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01310972, "Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01310972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*